News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 1, 2021

Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

Author(s)Todd Frieze, MD, FACP, FACE

Expert discusses the clinical manifestations and physiological implications of hypothyroidism, in addition to screening and diagnosis of this disease.

Episodes in this series

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

ACIP revises recommendation for universal infant vaccination against hepatitis B

Physicians taking back medicine: The rising toll of private equity in health care

How far will patients go for primary care? Survey finds travel thresholds vary

Improving patient financial experience: A strategic imperative

Osteopathic medical schools train physicians — and create a $6B economic effect

© 2025 MJH Life Sciences^®

All rights reserved.